Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes
Open Access
- 29 December 2009
- journal article
- clinical trial
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (3), 595-601
- https://doi.org/10.2337/dc09-1532
Abstract
OBJECTIVE: To simplify and improve the treatment of patients with type 1 diabetes, we ascertained whether the site of subcutaneous insulin infusion can be used for the measurement of glucose. RESEARCH DESIGN AND METHODS: Three special indwelling catheters (24-gauge microperfusion [MP] catheters) were inserted into the subcutaneous adipose tissue of subjects with type 1 diabetes (n = 10; all C-peptide negative). One MP catheter was perfused with short-acting insulin (100 units/ml, Aspart) and used for insulin delivery and simultaneous glucose sampling during an overnight fast and after ingestion of a standard glucose load (75 g). As controls, the further two MP catheters were perfused with an insulin-free solution (5% mannitol) and used for glucose sampling only. Plasma glucose was measured frequently at the bedside. RESULTS: Insulin delivery with the MP catheter was adequate to achieve and maintain normoglycemia during fasting and after glucose ingestion. Tissue glucose concentrations derived with the insulin-perfused catheter agreed well with plasma glucose levels. Median correlation coefficient and median absolute relative difference values were found to be 0.93 (interquartile range 0.91–0.97) and 10.9%, respectively. Error grid analysis indicated that the percentage number of tissue values falling in the clinically acceptable range is 99.6%. Comparable analysis results were obtained for the two mannitol-perfused catheters. CONCLUSIONS: Our data suggest that estimation of plasma glucose concentrations from the glucose levels directly observed at the site of subcutaneous insulin infusion is feasible and its quality is comparable to that of estimating plasma glucose concentrations from glucose levels measured in insulin-unexposed subcutaneous tissue.Keywords
This publication has 11 references indexed in Scilit:
- The role of new technologies in treating children and adolescents with type 1 diabetes mellitusPediatric Diabetes, 2007
- Feasibility of Automating Insulin Delivery for the Treatment of Type 1 DiabetesDiabetes, 2006
- Type 1 diabetesThe Lancet, 2006
- Closing the Loop: The Adicol ExperienceDiabetes Technology & Therapeutics, 2004
- Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment CriteriaDiabetes Technology & Therapeutics, 2003
- Continuous Subcutaneous Glucose Monitoring in Diabetic PatientsDiabetes Care, 2002
- Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion.American Journal of Physiology-Endocrinology and Metabolism, 1999
- Open-Flow Microperfusion of Subcutaneous Adipose Tissue for On-Line Continuous Ex Vivo Measurement of Glucose ConcentrationDiabetes Care, 1997
- Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood GlucoseDiabetes Care, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986